CHINA LESSO (02128) announced its interim results, with the profit attributable to equity holders approximately 727 million yuan, a year-on-year decrease of 30.53%.

18:50 28/08/2026

China Lianchuang (02128) announced its interim results for 2026, reporting a revenue decrease of 4.5% to RMB 11.912 billion, a gross profit decrease of 2.5% to RMB 3.426 billion, and a net profit decrease of 25.6% to RMB 695 million for the period. The profit attributable to owners of the company was approximately RMB 727 million, a year-on-year decrease of 30.53%. The basic earnings per share amounted to RMB 0.24.

CHINA LESSO (02128) announced its interim results for 2026, reporting a 4.5% decrease in revenue to RMB 11.912 billion, a 2.5% drop in gross profit to RMB 3.426 billion, and a 25.6% decline in net profit to RMB 695 million. The profit attributable to company owners was approximately RMB 727 million, a year-on-year decrease of 30.53%. The basic earnings per share were RMB 0.24.

CHINA RE (01508) announced its interim results, with a net profit attributable to shareholders of 7.187 billion yuan, an increase of 15.11% year-on-year.

BAMA TEA (06980) repurchased 3,900 shares at a cost of HKD 121,000 on August 28.

REDCO HEALTHY (02370) announced its interim results, reporting a net loss attributable to shareholders of approximately 2.6 million yuan, which represents a year-on-year narrowing of 55.14%.

CHINA RE (01508) announced its interim results, with a net profit attributable to shareholders of 7.187 billion yuan, an increase of 15.11% year-on-year.

BAMA TEA (06980) repurchased 3,900 shares at a cost of HKD 121,000 on August 28.

REDCO HEALTHY (02370) announced its interim results, reporting a net loss attributable to shareholders of approximately 2.6 million yuan, which represents a year-on-year narrowing of 55.14%.